The Problems of Long-Term Treatment With Benzodiazepines and Related Substances
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Benzodiazepine abuse and dependence have been recognized and widely discussed for more than 40 years. With more than 230 million daily doses prescribed in Germany per year, the burden of reimbursement on the statutory health insurance carriers is high, albeit with a slight decline from year to year. At present, about 50% of all prescriptions in Germany are issued privately, even for patients who have statutory health insurance. METHODS: We selectively review the literature on the epidemiology and treatment of benzodiazepine dependence and abuse in Germany. RESULTS: Estimates of the number of benzodiazepine-dependent persons in Germany range from 128 000 to 1.6 million. Most estimates take no account of the large number of private prescriptions (i.e., those that are not reimbursed by the statutory health insurance scheme), while many exclude prescriptions for elderly persons, for whom these drugs are frequently prescribed. For the outpatient treatment of benzodiazepine withdrawal, it is recommended that the drug should first be switched to an equivalent dose of another benzodiazepine with an intermediate or long-acting effect; the dose should then, in general, be reduced weekly. In case of consumption of a high dose (≥ 20 mg diazepam equivalent), hospitalization and the additional administration of carbamazepine or valproic acid are recommended. Flumazenil treatment can improve with - drawal symptoms and leads to higher abstinence rates. Antidepressants should be given only if the patient is depressed. The dependence potential of nonbenzodiazepine drugs such as zolpidem and zopiclon must also be borne in mind. CONCLUSION: Benzodiazepines are generally highly effective when first given, but they should generally be given only for strict indications and for a limited time. If these drugs still need to be given beyond the short term, timely referral to a specialist is indicated, and possibly also contact with the addiction aid system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Benzodiazepines revisited—will we ever learn?
Lader, M. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03563.x · Cited by 573
The diagnosis and management of benzodiazepine dependence
Ashton, H. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165594.60434.84 · Cited by 455
Hajak, G., Müller, W. E., Wittchen, H. U., Pittrow, D., & Kirch, W. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00491.x · Cited by 404
Strategies for discontinuing long-term benzodiazepine use: Meta-analysis
Voshaar, R. C. O., Couvée, J. E., Van Balkom, A. J. L. M., Mulder, P. G. H., & Zitman, F. G. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.189.3.213 · Cited by 205
Gerra, G., Zaimovic, A., Giusti, F., Moi, G., & Brewer, C. (2002) · Addiction Biology · doi:10.1080/1355621021000005973 · Cited by 82
Bobes, J., Rubio, G., Terán, A., Cervera, G., López-Gómez, V., Vilardaga, I., & Pérez, M. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2010.12.004 · Cited by 57
Vicens, C., Socias, I., Mateu, C., Leiva, A., Bejarano, F., Sempere, E., Basora, J., Palop, V., Mengual, M., Beltran, J. L., et al. (2011) · BMC Family Practice · doi:10.1186/1471-2296-12-23 · Cited by 26
Exploring the dark side of the moon: the treatment of benzodiazepine tolerance
Lugoboni, F., & Quaglio, G. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12148 · Cited by 21
Hochverbrauch von Zolpidem und Zopiclon: Querschnittsstudie auf Basis von Krankenkassendaten
Hoffmann, F., Pfannkuche, M., & Glaeske, G. (2008) · Der Nervenarzt · doi:10.1007/s00115-007-2280-6 · Cited by 21 · cited 1×
“Results The selective literature search regarding the epidemi ology identified 46 matches, of which four publications were relevant (4, 5, 14, 15).”
Background
Cited by
Relationship between the use of benzodiazepines and falls in older adults: a systematic review
Díaz-Gutiérrez, M. J., Martínez-Cengotitabengoa, M., Sáez de Adana, E., Cano, A. I., Martínez-Cengotitabengoa, M. T., Besga, A., Segarra, R., & González-Pinto, A. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.04.002 · Cited by 131
van der Kooij, M. A., Hollis, F., Lozano, L., Zalachoras, I., Abad, S., Zanoletti, O., Grosse, J., Guillot de Suduiraut, I., Canto, C., & Sandi, C. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.135 · Cited by 127
Chapoutot, M., Peter-Derex, L., Bastuji, H., Leslie, W., Schoendorff, B., Heinzer, R., Siclari, F., Nicolas, A., Lemoine, P., Higgins, S., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph181910222 · Cited by 59
“The prescription and use of BZDs has been under scrutiny for over 40 years [23] due to their many side effects [8,24,25].”
BackgroundLukačišinová, A., Fialová, D., Peel, N. M., Hubbard, R. E., Brkic, J., Onder, G., Topinková, E., Gindin, J., Shochat, T., Gray, L., et al. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02213-x · Cited by 35
Wolf, I.-K., Du, Y., & Knopf, H. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1254-x · Cited by 28
“This is particularly relevant for the use of benzodiazepines as in Germany about 50% of benzodiazepine prescriptions are prescribed privately [7] and therefore are not recorded by health insurance data.”
Background
Metadata
- Authors
- Janhsen, K., Roser, P., & Hoffmann, K.
- Venue
- Deutsches Ärzteblatt international
- Publisher
- Deutscher Arzte-Verlag GmbH
- Published
- 2015-01-05
- Volume
- 112
- Issue
- 1-2
- Pages
- 1-7
- ISSN
- 1866-0452 (ISSN-L)
- OpenAlex
- W2183739768
- Cited by
- 114
- References
- 9
- FWCI
- 7.34
- Type
- journal article
- Language
- de
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.